Related by context. All words. (Click for frequent words.) 70 pharmacological interventions 70 cognitive behavioral therapies 67 behavioral interventions 67 pharmacological treatments 67 pharmacological approaches 66 psychodynamic psychotherapy 66 nonpharmacologic 66 interpersonal psychotherapy 66 pharmacologic treatments 65 pharmacotherapies 65 biopsychosocial 65 Cognitive therapy 65 psychotherapeutic interventions 64 Cognitive behavioral 64 psychotherapeutic 63 psychopharmacological 63 psychodynamic therapy 63 Cognitive behavioral therapy 63 cognitive behavioral therapy 63 pharmacological therapies 63 biopsychosocial model 63 nonpharmacological 62 antiepileptics 62 psychosocial interventions 62 psychotherapy 62 poststroke depression 62 CAM modalities 61 psychodynamic 61 neuroleptics 61 maladaptive behaviors 61 pain syndromes 61 cognitive behavioral 60 topical NSAIDs 60 serotonin reuptake inhibitors 60 comorbid depression 60 hypochondriasis 60 acamprosate 60 dissociative disorders 60 fluoxetine Prozac 60 psychostimulants 60 Meta analyzes 60 neuropsychiatric diseases 60 psychoeducation 59 neuroimaging studies 59 anticonvulsants 59 depressive illnesses 59 paroxetine Paxil 59 analgesic medications 59 methodologically rigorous 59 RCTs 59 Atypical antipsychotics 59 Cognitive Behavioral Therapy 59 neuropsychiatric symptoms 59 pharmacotherapy 59 Muscle relaxants 59 Mindfulness Based Cognitive Therapy 59 somatoform disorders 59 psychiatric diagnoses 59 atypical antipsychotic medications 58 diagnosing ADHD 58 behavioral disinhibition 58 pharmacotherapeutic 58 Pharmacotherapy 58 antioxidant supplementation 58 EEG biofeedback 58 symptomatology 58 agomelatine 58 nonpharmacological treatments 58 meta analyzes 58 psychopharmacologic 58 psychotherapeutic treatments 58 motivational interviewing 58 non pharmacological interventions 58 neuroleptic drugs 58 Opioids 58 atypical neuroleptics 58 sociological theories 58 hyperactivity inattention 58 interventions 58 generalisability 58 neuropsychological impairments 58 comorbid disorders 58 convergent validity 58 randomized controlled trials RCTs 58 methodologic 58 antiplatelet therapies 57 Antidepressant medications 57 tricyclic antidepressants 57 neurobiological mechanisms 57 Cognitive Behavior Therapy 57 placebo controlled studies 57 therapeutic regimens 57 metaanalysis 57 direct thrombin inhibitors 57 venlafaxine Effexor 57 Interpersonal psychotherapy 57 somatic symptoms 57 CAM therapies 57 nondrug treatments 57 affective disorders 57 inhaled bronchodilators 57 pharmacologic interventions 57 therapy CBT 57 meta analytic 57 tic disorders 57 oral naltrexone 57 inhaled glucocorticoids 57 pharmacological therapy 57 pharmacologic approaches 57 dietary interventions 57 endophenotypes 57 psychobiological 57 methodological approaches 57 depot antipsychotics 57 anticholinergic agents 57 alexithymia 57 tiagabine 56 pathophysiological processes 56 Cognitive Behavioural Therapy 56 pharmacological intervention 56 psychiatric comorbidities 56 Psychodynamic 56 Pharmacologic 56 meta regression 56 neuroleptic 56 neural substrates 56 neuropsychological assessment 56 citalopram Celexa 56 Randomized trials 56 opiate dependence 56 psychostimulant 56 methodological limitations 56 psychoeducational 56 opioid dependent 56 osteopathic manipulation 56 lipid lowering agents 56 comorbid psychiatric disorders 56 Herbal remedies 56 antidepressant monotherapy 56 psychoactive medications 56 sertraline Zoloft 56 pyridostigmine 56 OSAHS 56 Cognitive Behavioural Therapy CBT 56 somatic complaints 56 Systematic reviews 56 RISPERDAL ® 56 psychiatric disorders 56 acute subacute 56 placebo controlled trials 56 etiologies 56 neurocognitive functioning 56 Glucocorticoids 56 tricyclic antidepressant 56 rheumatic diseases 56 Sleep disordered breathing 56 testosterone supplementation 56 suicide attempters 56 cognitive behavioral psychotherapy 56 syndromal 56 pathophysiologic mechanisms 56 neurocognitive deficits 56 cholinesterase inhibitors 56 Cognitive Behaviour Therapy 56 CB1 antagonists 56 tricyclics 55 MBCT 55 randomized controlled trials 55 prodromal symptoms 55 ski lls 55 amisulpride 55 colorectal carcinogenesis 55 statin medications 55 antidepressant efficacy 55 acetylcholinesterase inhibitors 55 overactive bladder symptoms 55 anticholinergic drugs 55 CLBP 55 newer atypical antipsychotic 55 randomized trials 55 newer atypical antipsychotics 55 Schema Therapy 55 oral NSAIDs 55 GnRH agonists 55 Spinal manipulation 55 TF CBT 55 antiandrogens 55 probiotic supplementation 55 guideline concordant 55 chlorpromazine 55 antipsychotic medications 55 Quantitative EEG 55 antiinflammatory drugs 55 Triptans 55 pathophysiological mechanisms 55 treating neuropathic pain 55 oral anticoagulation 55 psychopharmacology 55 developmental trajectories 55 multimodal analgesia 55 empirically validated 55 pharmacologic intervention 55 ConclusionThis 55 lipid parameters 55 aldosterone antagonists 55 meta analytic review 55 leukotriene receptor antagonists 55 orthomolecular 55 biphosphonates 55 AChE inhibitors 55 reuptake inhibitors 55 STEP BD 55 mood disorders 55 prostacyclins 55 neurocognitive function 55 nosology 55 polydrug 55 Mood stabilizers 55 dopamine antagonists 55 prospective observational studies 55 rheumatological 55 antidepressant therapy 55 neurocognition 55 Mood disorders 55 SGAs 55 therapeutic modalities 55 adjunctive therapies 55 chemopreventive agents 55 oncologic outcomes 55 clomipramine 55 cognitive domains 55 Motivational Interviewing 54 Cognitive Behavioral Therapy CBT 54 aetiology 54 topiramate Topamax 54 etiological factors 54 typical antipsychotics 54 H2 receptor antagonists 54 nonadherence 54 noncancer pain 54 psychiatric morbidity 54 fluoxetine paroxetine 54 antidepressants SSRIs 54 underlying molecular mechanisms 54 schizophrenia schizoaffective disorder 54 pramipexole Mirapex 54 opioid misuse 54 citalopram 54 psychosocial stressors 54 aldosterone antagonist 54 pharmacologic therapies 54 antiplatelet medications 54 Wernicke Korsakoff syndrome 54 neurocognitive impairment 54 biologic DMARDs 54 triptans 54 serotonin norepinephrine reuptake inhibitors 54 diagnosing bipolar disorder 54 pharmacologic 54 psychotropics 54 meta cognitive 54 Subgroup analyzes 54 gabapentin Neurontin 54 integrative approaches 54 Kraepelin 54 primidone 54 opiod 54 intersexuality 54 CYP#D# inhibitors 54 Longitudinal studies 54 electro acupuncture 54 compensatory mechanisms 54 vasodilators 54 intranasal corticosteroids 54 opioid medications 54 BEXXAR therapeutic regimen 54 somatization 54 androgen depletion 54 Orthomolecular 54 spinal manipulation 54 Antihistamines 54 INVEGA ® 54 Comorbid 54 pramlintide metreleptin combination 54 risperidone Risperdal 54 Cognitive impairment 54 psychosocial distress 54 pharmacodynamic parameters 54 Electroconvulsive therapy 54 Mellaril 54 Clinical Psychiatry 54 NMDA receptor antagonists 54 Venous thromboembolism 54 overdiagnose 54 psychoneuroimmunology 54 nondepressed 54 nocturnal enuresis 54 Lenzenweger 54 unipolar depression 54 exploratory endpoints 54 lipid abnormalities 54 glial tumors 54 euthymic 54 psychiatric comorbidity 54 prognostic indicators 54 Corticosteroids 54 Effexor venlafaxine 54 Herbal medicines 54 pathogenic mechanisms 54 nutrient supplementation 54 etiologic factors 54 intracranial hypertension 54 comorbid diagnoses 54 somatostatin analogs 54 orofacial pain 54 riociguat 54 Relaxation techniques 53 dietary modification 53 anticholinergic effects 53 multicenter trials 53 comorbid anxiety 53 Integrative medicine 53 sertraline 53 therapies 53 reflux symptoms 53 SAMe 53 vertebral subluxation 53 neurobiological underpinnings 53 parasomnias 53 epilepsies 53 anticonvulsant medications 53 euthymic patients 53 anxiolytics 53 depression schizophrenia bipolar 53 infantile colic 53 mindfulness meditation 53 HMG CoA reductase inhibitors 53 etiological 53 Major Depressive Disorder 53 polyarticular 53 HIV HCV coinfected 53 Timothy Botello 53 inhaled bronchodilator 53 urinary incontinence UI 53 chronic myocardial ischemia 53 mu opioid agonist analgesics 53 constipation OIC 53 dissociative symptoms 53 hypnotics 53 immunosuppressive agents 53 thiazide 53 electroconvulsive therapy ECT 53 subthreshold depression 53 immunological mechanisms 53 untreated psychosis 53 noncognitive 53 Quetiapine 53 steroid inhalers 53 sulfasalazine 53 predictive validity 53 oral antidiabetes drugs 53 oxcarbazepine 53 metabolic parameters 53 selective serotonin reuptake inhibitor 53 acupuncture meditation 53 VADT 53 ADHD symptoms 53 CYP#A# inhibitors 53 depressive symptomatology 53 destigmatizing 53 primary dysmenorrhoea 53 pathogenetic mechanisms 53 Roxana Mehran MD 53 GI motility disorders 53 antiplatelet drugs 53 diagnosing autism 53 cognitive deficits 53 Selective Serotonin Reuptake Inhibitors 53 paliperidone 53 androgen depletion therapy 53 infliximab Remicade 53 dosage regimens 53 Miklowitz 53 bipolar disorder schizophrenia 53 antidepressant medications 53 physiologic mechanisms 53 analgesic effects 53 chronic noncancer pain 53 manic depression bipolar disorder 53 Substance misuse 53 psychiatric illnesses 53 allergen avoidance 53 dyslipidaemia 53 melatonin supplements 53 Reprocessing EMDR 53 chronic relapsing 53 chronicity 53 psychotic disorders 53 coinfected patients 53 psychometric properties 53 Prozac fluoxetine 53 antenatal depression 53 neurochemistry 53 psychopathology 53 countertransference 53 β blockers 53 antiepileptic drugs AEDs 53 serotonin reuptake inhibitors SSRIs 53 antihypertensive therapy 53 subsyndromal 53 physician assistants PAs 53 Anti depressants 53 extrapyramidal symptoms EPS 53 selective serotonin reuptake inhibitors 53 abstinent alcoholics 53 addictive disorders 53 Psychosocial interventions 53 trials RCTs 53 nociceptive pain 53 dyslipidemias 53 drugless 53 longitudinal studies 53 N acetylcysteine 53 immunomodulatory agents 53 acting injectable formulation 53 lung cancer chemoprevention 53 underlying pathophysiology 53 psychopathologies 53 topical corticosteroids 53 comorbid conditions 52 duloxetine Cymbalta 52 ursodeoxycholic acid 52 unmeasured factors 52 neurosteroid 52 antidepressive 52 aromatase inhibitors AIs 52 Abatacept 52 adjuvant therapies 52 ziconotide 52 MAO inhibitors 52 neuroimaging 52 neurologic disorders 52 topical calcineurin inhibitors 52 symptomatic hyponatremia 52 psychoactive drugs 52 empiric therapy 52 Decety 52 comorbid psychiatric 52 causal pathways 52 allopathic medicine 52 baclofen 52 William Sandborn MD 52 SSRI antidepressant 52 CYP#D# inhibitor 52 varenicline Chantix 52 acting insulin analogues 52 coxibs 52 juvenile idiopathic arthritis JIA 52 subgroup analyzes 52 buproprion 52 pulmonary hypertension PH 52 selenium supplementation 52 DPNP 52 naturopathic remedies 52 LTRA 52 KRAS variant 52 postoperative AF 52 INVEGA R 52 functional gastrointestinal disorders 52 neurobiological basis 52 Selective serotonin reuptake inhibitors 52 vascular endothelial dysfunction 52 acid suppressing 52 prognostic markers 52 phosphodiesterase inhibitors 52 prospective longitudinal 52 atypicals 52 Th2 responses 52 BEXXAR Therapeutic Regimen 52 MBSR 52 substance misusers 52 shorter telomere length 52 pleiotropy 52 glitazones 52 disease modifying antirheumatic 52 linear pharmacokinetics 52 5 HT6 receptor 52 pimozide 52 Rasenick 52 Relapse Prevention 52 thoracoscopic lobectomy 52 bronchodilators 52 epidural steroid injections 52 antidepression 52 EFFEXOR XR 52 Oppositional Defiant Disorder 52 neuroanatomical 52 depressive symptom 52 periprocedural MI 52 biologic plausibility 52 Pathological gambling 52 LHRH antagonists 52 cytotoxic agents 52 Perforomist ™ Inhalation Solution 52 psychostimulant drugs 52 neuropsychological impairment 52 Prenatal Alcohol 52 Methylphenidate 52 antiemetics 52 antiepileptic medications 52 Personality traits 52 coexisting disorders 52 Guaifenesin 52 psychiatry 52 Homeopathic remedies 52 psychosocial functioning 52 complementary therapies 52 chronic LBP 52 pharmacological 52 IBS sufferers 52 dialectical behavioral 52 PROMETA Treatment Program 52 opiate analgesics 52 opioid naive 52 generalized epilepsy 52 neurobiological 52 tumor subtype 52 depression suicidal ideation 52 antibiotic regimens 52 HRQL 52 nortriptyline Pamelor 52 selective serotonin uptake 52 androgen excess 52 HATE CPAP 52 bronchopulmonary dysplasia BPD 52 flecainide 52 inotropic agents 52 Suicidal ideation 52 theoretical frameworks 52 generalizability 52 pharmacologic therapy 52 mitochondrial toxicity 52 poststroke 52 stress cardiomyopathy 52 cannabis induced psychosis 52 antithrombotic therapy 52 SNRIs 52 rheumatic disorders 52 anticholinergics 52 anti convulsants 52 electroconvulsive treatment 52 Guided imagery 52 locomotor training 52 NUCYNTA ™ 52 Risperidone 52 Anti psychotics 52 therapeutic armamentarium 52 H2 antagonists 52 reboxetine 52 Comorbidity 52 emotional dysregulation 52 Arthrizyme ™ 52 correlational 52 didactic lectures 52 Inflammatory Bowel Diseases 52 psychotic symptoms 52 GlaxoSmithKline Plc Paxil 52 Venlafaxine 52 differential diagnoses 52 Ritalin methylphenidate 52 bipolar illness 52 SSRI SNRI 52 methodologically sound 52 psychophysiological 52 statin simvastatin 52 Obsessive compulsive disorder OCD 52 Imipramine 52 psychotic illnesses 52 Genetic predisposition 52 therapeutic interventions 52 immunosuppressive therapies 52 molecular mechanisms underlying 52 uric acid lowering 52 somatization disorder 52 hawthorn extract 52 Psychoanalysts 52 genomic alterations 52 antihypertensive agents 52 paroxetine sertraline 52 angiotensin II receptor blockers 52 creatine supplementation 52 Comparative effectiveness 52 primary aldosteronism 52 anti androgens 52 prescribed opioids 52 postexposure prophylaxis 52 Naturopathic doctors 52 AGILECT R 52 Youdim 52 chronic neuropathic pain 52 Rheumatoid Arthritis RA 52 HAART regimens 52 psychoanalytic psychotherapy 52 Anxiety disorders 52 prazosin 52 pressor response 52 Corticosteroid injections 52 diabetic gastroparesis 52 Calorie restriction 52 adult neurogenesis 52 disulfiram 51 vardenafil Levitra 51 COX enzymes 51 dually diagnosed 51 beta agonists 51 sexual dysfunctions 51 bulimia nervosa 51 opioids 51 depressive disorders 51 Lofexidine 51 narcotic analgesics 51 HPA axis 51 Pagoclone 51 metabolic abnormalities 51 NMDA antagonists 51 immunological responses 51 trastuzumab Herceptin ® 51 prophylactic anticoagulation 51 migraine prophylaxis 51 regression analyzes 51 biobehavioral 51 underdiagnosis 51 BoNTA 51 homoeopathic remedies 51 Aggrastat ® tirofiban hydrochloride 51 EEG abnormalities 51 protease inhibitor PI 51 cognitive affective 51 premenstrual syndrome PMS 51 androgen deprivation 51 AMOR IPAT 51 rheumatologic 51 Barbara Sahakian 51 neuropsychological functioning 51 causal inference 51 Teriflunomide 51 sedative hypnotics 51 nucleoside analogues 51 opioid analgesics 51 antiandrogen 51 Korsakoff syndrome 51 stimulant medication 51 muscular dystrophies 51 Valdoxan 51 non steroidal anti inflammatories 51 psychosocial 51 androgen deficiency 51 Generalized Anxiety Disorder 51 cognitive enhancers 51 antianginal 51 hypomanic episodes 51 Non Steroidal Anti Inflammatory 51 aetiological 51 maximally tolerated lipid lowering 51 neuroinflammatory 51 unmeasured confounders 51 acupuncture biofeedback 51 sexual compulsivity 51 Kleinplatz 51 schizophrenia bipolar disorders 51 antitumour 51 NUCYNTA R 51 lipid lowering therapy 51 Topiramate 51 Risperdal Zyprexa 51 methylphenidate Ritalin 51 Anticonvulsant 51 nongenetic 51 TMS Therapy 51 pharmacogenetics 51 paricalcitol 51 myopathy rhabdomyolysis 51 Yurgelun Todd 51 chlorthalidone 51 mu opioid 51 LUTS 51 pharmacokinetic interactions 51 Observational studies 51 LC#m# vaccine 51 newer antidepressants 51 INVEGA ® SUSTENNA TM 51 clozapine Clozaril 51 conventional antipsychotics 51 SRIs 51 non selective NSAIDs 51 inotropes 51 ACCORD Eye 51 macrolide antibiotics 51 lipid lowering therapies 51 tricyclic 51 commonly prescribed antidepressants 51 Inhaled corticosteroids 51 JAK inhibitors 51 monoamine oxidase inhibitors 51 pharmacogenetic tests 51 hormonal therapies 51 OAB symptoms 51 PROMETA 51 ergot alkaloids 51 interventional therapies 51 thromboprophylaxis 51 atopic eczema 51 diagnostically 51 dysfunctional voiding 51 multivariate analyzes 51 molecularly targeted therapies 51 superficial bladder cancer 51 Behavioral Neurology 51 neuropsychiatric disorders 51 imatinib resistance 51 EMDR 51 bexarotene 51 activity MAOA 51 anti androgen 51 pathophysiological 51 relieving menopausal symptoms 51 medicine EBM 51 Transcranial Magnetic Stimulation TMS 51 neuro psychiatric disorders 51 Thyroid disorders 51 symptomology 51 non ulcer dyspepsia 51 neurodevelopmental outcome 51 GFT# 51 pharmacogenetic testing 51 Social Phobia 51 MMP inhibitors 51 buprenorphine naloxone 51 LLLT 51 hepatic metastases 51 breast cancer subtypes 51 CYT# potent vascular disrupting 51 endothelin receptor antagonists 51 longitudinal cohort 51 perinatal outcomes 51 syndromic 51 nonpsychiatric 51 dialectical behavior 51 PDE4 inhibitors 51 antihypertensive medications 51 subclinical disease 51 DHEA supplementation 51 Ginkgo extract 51 akinetic mutism 51 comorbidity 51 LHRH agonists 51 diarrhea flatulence 51 QTc intervals 51 geriatric syndromes 51 pediatric psychopharmacology 51 prescription opioid 51 escitalopram Lexapro 51 neuropsychological deficits 51 cardiovascular morbidity 51 SOCE 51 extrapyramidal symptoms 51 serotonin reuptake inhibitor 51 flavopiridol 51 Symptom severity 51 antisense compounds 51 venlafaxine XR 51 antidiabetic drugs 51 Acamprosate 51 activate AMPK 51 sotalol 51 T1DM 51 neuroregenerative 51 guanfacine 51 conventional angiography 51 antitumour activity 51 BARI 2D 51 chronic prostatitis chronic 51 Borderline Personality Disorder 51 androgen suppression 51 adjunct therapy 51 neuropsychological evaluations 51 opioid dependence 51 acute mania 51 prodromal phase 51 SSRI antidepressants 51 GABRA2 51 antiarrhythmic drug 51 subdisciplines 51 nonoperative treatment 51 androgen therapy 51 opioid analgesia 51 mental disorders 51 impulsive behaviors 51 researcher Kathleen Merikangas 51 haloperidol Haldol 51 reuptake inhibitor 51 carotid angioplasty 51 Opioid 51 neurodevelopmental disorders 51 psoriatic arthritis PsA 51 randomized clinical trials 51 sildenafil Viagra 51 late onset hypogonadism 51 orthomolecular medicine 51 Bertolote 51 Paliperidone ER 51 TNF alpha antagonist 51 thrombophilia 51 antiplatelet agents 51 opioid antagonists 51 venlafaxine 51 clobazam 51 ragweed allergic 51 recurrent glioblastoma multiforme 51 oral rivaroxaban 51 dopamine D2 receptors 51 AA Amyloidosis 51 schizophrenia 51 hepatotoxic 51 observable behaviors 51 mPFC 51 thiopurine 50 daytime drowsiness 50 manic depressive illness 50 psychological traumas 50 thyroid dysfunction 50 metabonomics 50 affective psychoses 50 SIRT1 activation 50 polypharmacy 50 neurosensory 50 pediatric bipolar disorder 50 aromatase inhibitor therapy 50 drugs DMARDs 50 dosing algorithm 50 calcineurin inhibitors 50 DSM IV Axis 50 Cardiotoxicity 50 dysphoric 50 dosage regimen 50 eating disorders anorexia nervosa 50 smoking cessation therapies 50 biochemical abnormalities 50 immunotherapeutic approaches 50 morbidities 50 anticonvulsant drugs 50 monoamines 50 symptom checklist 50 hyperarousal 50 discordant couples 50 pentoxifylline 50 generalizable 50 functional neuroimaging 50 variant angina 50 thromboembolic disease 50 ciliopathies 50 Multivariate logistic regression 50 MEVACOR 50 menstrual migraine 50 Dyspepsia Tachycardia Myalgia etc. 50 schizophrenics 50 prosocial behavior 50 Intervention Effectiveness 50 nonepileptic seizures 50 endoscopists 50 vitamin D inadequacy 50 phenelzine 50 paraphilias 50 antihypertensive drugs 50 newer antipsychotics 50 interferon therapy 50 tegaserod 50 endogenous opioid 50 methotrexate therapy 50 Susan Pinker 50 adrenal function 50 Binge Eating Disorder 50 chlamydial infection 50 thienopyridines 50 progranulin mutations 50 loop diuretics 50 Clinical Antipsychotic Trials 50 muscle dysmorphia 50 Nerve stimulation 50 acupuncture hypnosis 50 postmarketing surveillance 50 adenotonsillectomy 50 mu opioid agonists 50 randomized controlled clinical trials 50 bibliotherapy 50 stigmatizing attitudes 50 affective psychosis 50 Liver toxicity 50 chemotherapeutic regimens 50 nondrug approaches 50 antiarrhythmic drugs 50 Paroxetine 50 patient subpopulations 50 psychosomatic medicine 50 schizophrenia bipolar 50 DMARDs 50 Bulimia Nervosa 50 Relieve Depression 50 adjuvant systemic 50 tolerability profiles 50 Angiotensin receptor blockers 50 FSAD 50 Helicobacter pylori eradication 50 GPi 50 cardiometabolic risk 50 Adjunctive 50 analgesic efficacy 50 renoprotective 50 glucose abnormalities 50 Zevalin consolidation 50 noncardiac chest pain 50 cortical excitability 50 antithrombotic agents 50 Complementary therapies 50 Oreopoulos 50 postmenopausal hormone 50 bioinformatic approaches 50 thyrotropin 50 inactivated influenza vaccines 50 posttraumatic stress disorder PTSD 50 anxiety disorders 50 recurrent miscarriage 50 anti depressant medications 50 Prostatitis 50 Dopamine agonists 50 Personality disorders 50 nasal irrigation 50 HRQOL 50 Lamotrigine 50 perfusion CT 50 systolic hypertension 50 anti arrhythmic drugs 50 mycophenolate mofetil 50 Neuromonics Tinnitus Treatment 50 Bipolar Mania 50 Temporal lobe epilepsy 50 Schlaggar 50 Comorbidities 50 Topical treatments 50 Clinically 50 anxiolytic 50 Autism Spectrum Disorders ASDs 50 neovascular glaucoma 50 comorbid substance 50 antiangiogenic agents 50 GABRA2 gene 50 NovaBay Aganocide compounds 50 Cardiopulmonary bypass 50 SERMs 50 Mindfulness meditation 50 nonrandomized studies 50 FOSRENOL ® 50 heritable disorders 50 confusional arousals 50 EGFR antibodies 50 Psychiatric Disorders 50 Sociodemographic 50 eculizumab therapy 50 clozapine 50 genetic loci 50 emotional lability 50 rTMS 50 mechanistic studies 50 Naturopathic medicine 50 osteoarthritis rheumatoid arthritis 50 STRATEGY FOR AN OPEN 50 attempters 50 opioid induced 50 Membrane proteins 50 chronic periodontitis 50 ginkgo extract 50 undertreatment 50 anti epileptics 50 rheumatoid arthritis osteoarthritis ankylosing 50 intravenous bisphosphonates 50 menopausal symptom 50 Dose adjustments 50 Psychometric tests 50 dietary antioxidants 50 comorbid ADHD 50 antituberculosis 50 intensive statin therapy 50 Cochrane Database 50 Markus Heilig 50 induce orthostatic hypotension 50 MAOIs 50 postsurgical pain 50 biomedically 50 hypercholesterolemia